Cav beta 2 Ca+2 Channel Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-Cav beta 2 Ca+2 Channel antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCav beta 2 Ca+2 Channel
Clone[S8b-1]
Host SpeciesMouse
Reactive Speciesn/a
IsotypeIgG1
Formatunconjugated
Size0.1 mg
Concentrationn/a
ApplicationsImmunoblot (IB); Immunohistochemistry (IHC); Immunocytochemistry (ICC); Immunofluorescence (IF)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThis antibody recognizes human, mouse, and rat Cavbeta2. It does not cross-react with Cav beta1, Cav beta3, or Cav beta4. Ion channels are integral membrane proteins that help establish and control the small voltage gradient across the plasma membrane of living cells by allowing the flow of ions down their electrochemical gradient. Cavbeta subunits are involved in the transport of the pore-forming alpha1 subunit to the plasma membrane. They also shield an ER Retention signal on the alpha1 subunit, thereby guiding the poreforming subunit to the target membrane.
Immunogenn/a
Other Names[voltage-dependent L-type calcium channel subunit beta-2; Voltage-dependent L-type calcium channel subunit beta-2; voltage-dependent L-type calcium channel subunit beta-2; CAB2; calcium channel voltage-dependent subunit beta 2; calcium channel, voltage-dependent, beta 2 subunit; Calcium channel voltage-dependent subunit beta 2], [Cacnb2; Cacnb2; Cacnlb2; Cacnlb2]
Gene, Accession #Gene ID: 116600, NCBI: NP_446303.1, UniProt: Q8VGC3
Catalog #MBS190548
Price$410
Order / More InfoCav beta 2 Ca+2 Channel Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.